Cisgender? Transgender? Intersex? There’s much to talk about in sexual health and ASHA sorts out the terminology.
ASHA’s podcast features a conversation on men’s sexual health with ASHA board member Dr. Abe Morgentaler.
Get involved! Become an Ambassador and help us spread the word about positive, safe, and scientifically-based sexual health for women.
Condomology: a collection of fact-based information (including fact sheets and videos) in simple, easy-to-understand language
Sexual Health TV: Sexual Health TV (SHTV) is your one stop for a wide range of sexual health programming. Tune in to watch all the channels including one dedicated to condoms and risk reduction.
#KeepItCovered #CondomMonth blog on sex, alcohol, and making good choices.
Below are sample Tweets and Facebook posts you can share throughout the month:
Wrap it up! February is National Condom Month. Learn more @ http://ow.ly/XOQj8 #CondomMonth
Free fact sheet download – Male Condoms & Female Condoms. http://ow.ly/XOR8H #CondomMonth
How to Use a Condom animation. http://ow.ly/XORou #CondomMonth
ASHA’s Condomology busts myths & gets out the facts about condoms. Plain language to empower YOU. http://ow.ly/XOQId #CondomMonth
February is National Condom Month (#CondomMonth). Visit ASHA to learn more. It’s YOUR health – take charge and be safe!
During National Condom Month in January ASHA is offering a free download of the fact sheet Male Condoms & Female Condoms. Get yours at ASHA. #CondomMonth
During National Condom Month in February you can download fact sheets and more from ASHA. Get involved, make a difference! #CondomMonth
Condomology is an ASHA program to ensure that the facts about condoms are available and understood by all so consumers can make informed choices about their sexual health. FAQs, posters, videos, and more. Get the facts and take control of your sexual health. #CondomMonth
On June 4, 2015, an FDA advisory committee recommended approval of flibanserin, a drug to treat low sexual desire (known as hypoactive sexual desire disorder or HSDD) in women. The committee did make its approval contingent of steps being made to make women aware of the potential side effects of the drug, including low blood pressure, fainting, nausea and dizziness.
The final decision on the drug will be made by the full FDA in August. While recommendations of advisory committees aren’t binding, the FDA frequently follows their guidance. If approved, flibanserin, manufactured by Sprout Pharmacueticals, would become the first medication on the market to treat HSDD in women.
ASHA’s President and CEO, Lynn Barclay, spoke at the advisory committee meeting. A full transcript of her remarks are below.
Good afternoon. I’m Lynn Barclay, the President of the American Sexual Health Association.
Our organization was founded more than 100 years ago. In that century of working in sexual health, it’s been apparent from the early days that there is seldom a one-size-fits-all answer to the many challenges real people face in achieving and maintaining sexual health and satisfying sex lives. What works well for one may not be nearly enough for another, so the best approach is often an array of solutions that are as diverse as the populations we serve.
We firmly believe this to be the case with women just like me who are struggling with issues of sexual desire. Let’s face it, this is a complex issue! Sexual desire is an interesting brew of mind and body, with a dash of society and a pinch of interpersonal issues tossed in. For some women these matters are best addressed with a bottle of champagne, a romantic stroll on the beach, or good therapy. Other women need something else, maybe a combination of things. What makes me sad, worried, and to be honest annoyed is that there are NO medical options available for women for whom biological factors are at play. Not….one. This for a condition the FDA itself recognizes as a top unmet medical need in the U.S.
Our organization believes sexual health should not be seen as separate from our overall health; each impacts the other. Sexual health is, in our view, not a privilege but a right. We believe BOTH men and women as well as their healthcare providers should have choices in addressing sexual dysfunction. We also believe that women – and men- can be trusted to decide for themselves about using an FDA-approved and health care provider-prescribed treatment option.
We applaud you for this focus on women’s sexual health, which really, is a focus on women’s health. This is about a woman’s well-being, her quality of life. And you better believe it affects her partner, too. You’ve heard the saying “If mama ain’t happy, ain’t nobody happy”? Well, as grammatically imperfect as that may be, it makes a good point. Let’s make sure mamas, grandmas, aunts, sisters, and women just like me everywhere have a complete menu of choices. We deserve it, we are worth it, and in the end we’ll all be better for it.
On October 27, the Food and Drug Administration conducted a patient-focused public meeting on female sexual dysfunction (FSD), with a special focus on female sexual interest/arousal disorder (FSIAD). The meeting included personal stories from patients on the impact of FSD on their lives and relationships as well as comments from advocates on the need for more treatment options.
ASHA’s VP of Health Policy, Deborah Arrindell, pictured at left, was among those at the meeting to offer comment and urge the FDA to provide more options for women suffering from FSD. You can listen to Deborah’s comments (and the enthusiastic applause that follows) below.
Transcript of Deborah Arrindell’s Comments
Good afternoon. I’m Deborah Arrindell with the American Sexual Health Association. Our organization was established in 1914 when women were largely considered vixens, vectors of infection, and maybe vamps. It’s wonderful that we’ve come to the point where we can begin to talk about women having healthy sexual lives. That women have a right, perhaps, to desire, arousal, even pleasure. So we really appreciate that the FDA has today given organizations like mine and people like me an opportunity to hear from patients—things that I have only read about.
What I’ve heard is despair, anxiety, loss of confidence, loss of self worth, troubled relationships, and families in crisis. And sexual health, we believe, is basic human right. What we’ve heard is that women will try everything, including, quote, “some things I don’t even remember the names of.” And indeed, I believe that for some women, chocolate, strawberries, and certain episodes of Grey’s Anatomy can make a difference. But for many other women, that is simply not the case. We heard that for some women, a month in the Caribbean will not do the trick. Not being able to have sexual desire will only add to anxiety there.
So I believe that sexual health is a basic human right and those are the women for whom we ask the FDA to provide some options. We don’t want a magic pill. We want an opportunity for those women and their providers to together figure out what’s right for them and what might work.
I believe that deeply buried in the Constitution there must be a basic right to healthy sexuality. I’m gonna go with the pursuit of happiness. Thank you.